Jacobi Capital Management’s Exact Sciences EXAS Stock Holding History

Jacobi Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-165	Closed	-$16K	–	696
2021 Q3	$16K	Sell	165 -55	-25%	-$5.81K	﹤0.01%	939
2021 Q2	$27K	Hold	220	–	–	﹤0.01%	763
2021 Q1	$29K	Buy	220 +55	+33%	+$7.53K	﹤0.01%	704
2020 Q4	$22K	Hold	165	–	–	﹤0.01%	698
2020 Q3	$17K	Hold	165	–	–	﹤0.01%	704
2020 Q2	$14K	Buy	165 +70	+74%	+$5.59K	﹤0.01%	714
2020 Q1	$6K	Hold	95	–	–	﹤0.01%	786
2019 Q4	$9K	Buy	+95	New	+$8.35K	﹤0.01%	759

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jacobi Capital Management's EXAS Position: Q4 2021 in Review

Jacobi Capital Management sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 165 shares — an estimated $16K sold.

Jacobi Capital Management first reported a position in EXAS in Q4 2019 and held it in 8 quarters. The position peaked at $29K in Q1 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

Jacobi Capital Management reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 165 Exact Sciences shares in Q4 2021, an estimated $16K.
Jacobi Capital Management first reported a position in Exact Sciences in Q4 2019 and held it in 8 quarters.
Jacobi Capital Management's Exact Sciences position peaked at $29K in Q1 2021.
596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.